Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$402.4 - $446.42 $1.78 Million - $1.98 Million
-4,428 Reduced 66.51%
2,230 $969,000
Q2 2023

Aug 14, 2023

BUY
$354.01 - $427.31 $670,848 - $809,752
1,895 Added 39.79%
6,658 $2.85 Million
Q1 2023

May 15, 2023

BUY
$335.35 - $386.06 $1.6 Million - $1.84 Million
4,763 New
4,763 $1.7 Million
Q3 2022

Nov 14, 2022

BUY
$321.25 - $373.84 $3.53 Million - $4.1 Million
10,975 New
10,975 $3.73 Million
Q1 2022

May 16, 2022

SELL
$244.61 - $310.48 $912,639 - $1.16 Million
-3,731 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$198.21 - $248.9 $172,244 - $216,294
-869 Reduced 18.89%
3,731 $927,000
Q3 2021

Nov 15, 2021

BUY
$188.42 - $208.66 $866,732 - $959,836
4,600 New
4,600 $917,000
Q2 2021

Aug 13, 2021

SELL
$184.89 - $202.68 $1.16 Million - $1.27 Million
-6,285 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$169.52 - $196.53 $1.07 Million - $1.24 Million
6,285 New
6,285 $1.23 Million
Q3 2020

Nov 12, 2020

SELL
$140.89 - $159.9 $859,428 - $975,390
-6,100 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$125.49 - $164.68 $765,489 - $1 Million
6,100 New
6,100 $936,000
Q1 2020

May 15, 2020

SELL
$115.75 - $170.96 $451,425 - $666,744
-3,900 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$130.23 - $153.27 $91,161 - $107,289
-700 Reduced 15.22%
3,900 $539,000
Q3 2019

Nov 13, 2019

BUY
$134.24 - $148.53 $617,504 - $683,238
4,600 New
4,600 $629,000
Q1 2018

May 15, 2018

SELL
$138.75 - $176.72 $1.71 Million - $2.17 Million
-12,304 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$135.02 - $162.6 $1.66 Million - $2 Million
12,304
12,304 $1.92 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $74.7B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.